$Unitedhealth(UNH.US) has earnings soon. A move over the 21ma/378 area next on my radar.
Source: Sunrise Trader
What's on your mind?
$Unitedhealth(UNH.US) | Bernstein SocGen Group ๐ฟ๐ฒ๐ถ๐๐ฒ๐ฟ๐ฎ๐๐ฒ๐ ๐ข๐๐๐ฝ๐ฒ๐ฟ๐ณ๐ผ๐ฟ๐บ on ๐จ๐ป๐ถ๐๐ฒ๐ฑ๐๐ฒ๐ฎ๐น๐๐ต ๐๐ฟ๐ผ๐๐ฝ, maintains PT at $๐ฑ๐ญ๐ฎ
Analyst sees Optum Insight and AI as significant long-term growth opportunities for UnitedHealth Group.Here's a conveniently timed Trump trade
On 1/26, the government proposed paying UnitedHealth less per Medicare patient starting 2027$Unitedhealth(UNH.US) dropped 20% next dayHere's where it gets convenientStarting 2/23, Trump's portfolio bought $Unitedhealth(UNH.US) for four straight weeks, up to ~$345KOn 4/6, the government announced a 2.48% payment increase insteadThe stock is up 42% since his February buyWhite House says there's no conflict of interest
Orders
Traded Value$Unitedhealth(UNH.US)UnitedHealth closed at $401.67, down 13% from its July high of $461.62 but up 58% from its May 2025 crash low. Q2 2026 EPS surged 61.5% YoY to $6.04 with FCF nearly doubling, though revenue growth flattened near zero. Multiple daily oscillators flash oversold with Bollinger lower-band support at $396 being tested. Forward PE sits at 25.4x, near its 5-year median, while dividend yield has climbed to a 5-year high of 2.24%.
Here is every top $SPY performer (RP>85) currently sitting near the 50 day SMA ๐
$Unitedhealth(UNH.US)$Datadog(DDOG.US)$GE Vernova(GEV.US)$Analog Devices(ADI.US)$Lumentum(LITE.US)$FedEx(FDX.US)$Centene(CNC.US)$Keysight Tech(KEYS.US) $F5(FFIV.US)$Moderna(MRNA.US) $Casey General Stores(CASY.US)$Teradyne(TER.US)$Humana(HUM.US) $Cisco(CSCO.US) $Targa Resources(TRGP.US)
Orders
Traded Value$Unitedhealth(UNH.US)UnitedHealth (UNH) is showing a solid recovery in my portfolio, currently sitting at +18.44% with the market price around $407.08 versus my average cost of $343.33. Iโm still holding with a longer-term view, as I believe the recent weakness created an attractive entry point. The recovery has been encouraging, but Iโm staying patient and watching the companyโs fundamentals and future growth closely. #TradeShowcase
Orders
Traded Value$Unitedhealth(UNH.US)Holding UnitedHealth through the volatility is finally paying off. My position is now sitting at +20.38%, and this is a great reminder that patience often rewards investors who stick to their conviction instead of reacting to every short-term headline. ๐
Iโm not rushing to celebrate or lock in profits just yet. Iโll continue monitoring earnings, business fundamentals, and the overall healthcare sector before making my next move. Every successful investment reinforces the importance of having a plan, managing risk, and letting time work in your favor. Wishing everyone green portfolios and disciplined investing! ๐ช๐๐
Orders
Traded Value$Unitedhealth(UNH.US)UNH closed at $419.08 on Friday, sitting right on the 30-day MA (~$419) after pulling back from the $434 Bollinger upper band. A few things Iโm watching closely:
Technicals are flashing caution, but also potential support. KDJ is deeply oversold (K at 24, J at 9), ARBR shows an extremely oversold BR reading, and the PSY indicator just broke below its moving average โ short-term selling pressure is real. However, MACD remains above the zero line, meaning the broader uptrend hasnโt fully reversed yet.
The setup matters. Price is now testing the 30-day MA as support. If this level holds, it could be a solid re-entry zone for those who missed the prior leg up. A break below $415 (Bollinger lower band) would change the picture.
$Unitedhealth(UNH.US) | BofA Securities reiterates ๐๐ฎ๐ฒ on ๐๐ง๐ข๐ญ๐๐๐๐๐๐ฅ๐ญ๐ก ๐๐ซ๐จ๐ฎ๐ฉ, ๐ซ๐๐ข๐ฌ๐๐ฌ ๐๐ ๐ญ๐จ $๐๐๐
Analyst sees an impressive quarter with a 31% consensus beat and 12% guidance raise, driven by strong margin expansion across UHC and Optum.
Orders
Traded Value$Unitedhealth(UNH.US)+23.30% on UNH and still holding. This position has been a great reminder that patience often pays off. While market sentiment around UnitedHealth has been volatile, I chose to stay focused on the companyโs long-term fundamentals instead of reacting to short-term price swings. Todayโs gain is encouraging, but Iโm not treating it as the finish line. Iโll continue monitoring earnings, regulatory developments, and business execution while letting the investment thesis play out. Staying disciplined and avoiding emotional decisions has been one of the biggest lessons from this trade. Looking forward to seeing how this position performs over the long run.
